Efficacy of pemetrexed in relapsed non-small cell lung cancer and thymidylate synthase expression

Tuberculosis and Respiratory Diseases

Volumn 67, Issue 3, 2009, Pages 191-198

  Park, Choel Kyu ^a   Kim, Kyu Sik ^a   Oh, In Jae ^a   Tseden Ish, Manaljav ^a,b   Choi, Yoo Duk ^a   Kwon, Yong Soo ^a   Kim, Yoo Il ^a   Lim, Sung Chul ^a   Kim, Young Chul ^a,c  

^a Chonnam National University Medical School   (South Korea)

^b Chonnam National University   (South Korea)

^c Chonnam National University Research Institute of Medical Sciences   (South Korea)

Author keywords

Non small cell lung cancer; Pemetrexed; Thymidylate synthase

Indexed keywords

PEMETREXED; THYMIDYLATE SYNTHASE;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RELAPSE; CANCER SURVIVAL; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION;

EID: 70350050844     PISSN: 17383536     EISSN: None     Source Type: Journal    
DOI: 10.4046/trd.2009.67.3.191     Document Type: Article

References (24)

1. In KH, Kwon YS, Oh IJ, Kim KS, Jung MH, Lee KH, et al. Lung cancer patients who are asymptomatic at diagnosis show favorable prognosis: a korean Lung Cancer Registry Study. Lung Cancer 2009;64:232-237
2. Breathnach OS, Freidlin B, Conley B, Green MR, Johnson DH, Gandara DR, et al. Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results. J Clin Oncol 2001;19:1734-1742 (Pubitemid 32230875)
3. Shepherd FA, Dancey J, Ramlau R, Mattson K, Gralla R, O'Rourke M, et al. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy. J Clin Oncol 2000:18:2095-103. (Pubitemid 30324363)
4. Hanna N, Shepherd FA, Fossella FV, Pereira JR, De Marinis F, von Pawel J, et al. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small cell lung cancer previously treated with chemotherapy. J Clin Oncol 2004;22:1589-1597 (Pubitemid 41079796)
5. Shepherd FA, Rodrigues Pereira J, Ciuleanu T, Tan EH, Hirsh V, Thongprasert S, et al. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 2005;353:123-132 (Pubitemid 41058344)
6. Murillo JR, Koeller J. Chemotherapy given near the end of life by community oncologists for advanced non-small cell lung cancer. Oncologist 2006;11:1095-1099 (Pubitemid 44788401)
7. Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003;21:2636-2644 (Pubitemid 46606305)
8. Scagliotti GV, Parikh P, von Pawel J, Biesma B, Vansteenkiste J, Manegold C, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 2008;26:3543-3551
9. Nakagawa T, Otake Y, Yanagihara K, Miyahara R, Ishikawa S, Fukushima M, et al. Expression of thymidylate synthase is correlated with proliferative activity in non-small cell lung cancer (NSCLC). Lung Cancer 2004;43:145-149
10. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-216
11. Pfister DG, Johnson DH, Azzoli CG, Sause W, Smith TJ, Baker S Jr, et al. American Society of Clinical Oncology treatment of unresectable non- small cell lung cancer guideline: update 2003. J Clin Oncol 2004;22:330-353 (Pubitemid 41095099)
12. Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002;346:92-98 (Pubitemid 34438899)
13. Korean Association for the Study of Lung Cancer. Clinical practice guidelines in oncology. Non-small cell lung cancer [Internet]. Seoul: Korean Association for the Study of Lung Cancer; 2009 [cited Jul 2009]. Available from: http://www.lungca.or.kr.
14. Rossi A, Ricciardi S, Maione P, de Marinis F, Gridelli C. Pemetrexed in the treatment of advanced non-squamous lung cancer. Lung Cancer. Forthcoming 2009. Lung Cancer 2009 Jul 3 [Epub ahead of print].
15. de Marinis F, Grossi F. Clinical evidence for second- and third-line treatment options in advanced non-small cell lung cancer. Oncologist 2008; 13 Suppl 1:14-20.
16. Massarelli E, Andre F, Liu DD, Lee JJ, Wolf M, Fandi A, et al. A retrospective analysis of the outcome of patients who have received two prior chemotherapy regimens including platinum and docetaxel for recurrent non-small cell lung cancer. Lung Cancer 2003;39:55-61. (Pubitemid 36020295)
17. Sun JM, Lee KW, Kim JH, Kim YJ, Yoon HI, Lee JH, et al. Efficacy and toxicity of pemetrexed as a third-line treatment for non-small cell lung cancer. Jpn J Clin Oncol 2009;39:27-32.
18. Rustum YM, Harstrick A, Cao S, Vanhoefer U, Yin MB, Wilke H, et al. Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitors. J Clin Oncol 1997;15:389-400. (Pubitemid 27020596)
19. Rodriguez-Bigas MA, Petrelli NJ. Biochemical modulation of fluoropyrimidines and other drugs. In: Wanebo HJ, editor. Colorectal cancer. 1st ed. St. Louis: Mosby; 1993. p.509-522
20. Haqqani AS, Cowling RT, Maroun JA, Birnboim HC. Characterization of a polyclonal antibody to human thymidylate synthase suitable for the study of colorectal cancer specimens. J Histochem Cytochem 1999;47:1563-1574
21. Johnston PG, Fisher ER, Rockette HE, Fisher B, Wolmark N, Drake JC, et al. The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. J Clin Oncol 1994;12:2640-2647 (Pubitemid 24379651)
22. Johnston PG, Lenz HZ, Leichman CG, Danenberg KD, Allegra CJ, Danenberg PV, et al. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res 1995;55:1407-1412
23. Hanauske AR, Eismann U, Oberschmidt O, Pospisil H, Hoffmann S, Hanauske-Abel H, et al. In vitro chemosensitivity of freshly explanted tumor cells to pemetrexed is correlated with target gene expression. Invest New Drugs 2007;25:417-423
24. Ceppi P, Volante M, Saviozzi S, Rapa I, Novello S, Cambieri A, et al. Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase. Cancer 2006;107:1589-1596 (Pubitemid 44546920)